NCCN Guidelines Insights: Uterine Neoplasms, Version 3.2021. Journal of the National Comprehensive Cancer Network : JNCCN Abu-Rustum, N. R., Yashar, C. M., Bradley, K., Campos, S. M., Chino, J., Chon, H. S., Chu, C., Cohn, D., Crispens, M. A., Damast, S., Diver, E., Fisher, C. M., Frederick, P., Gaffney, D. K., George, S., Giuntoli, R., Han, E., Howitt, B., Huh, W. K., Lea, J., Mariani, A., Mutch, D., Nekhlyudov, L., Podoll, M., Remmenga, S. W., Reynolds, R. K., Salani, R., Sisodia, R., Soliman, P., Tanner, E., Ueda, S., Urban, R., Wethington, S. L., Wyse, E., Zanotti, K., McMillian, N. R., Motter, A. D. 2021; 19 (8): 888-895

Abstract

The NCCN Guidelines for Uterine Neoplasms provide recommendations for diagnostic workup, clinical staging, and treatment options for patients with endometrial cancer or uterine sarcoma. These NCCN Guidelines Insights focus on the recent addition of molecular profiling information to aid in accurate diagnosis, classification, and treatment of uterine sarcomas.

View details for DOI 10.6004/jnccn.2021.0038

View details for PubMedID 34416706